Clinical Trials

762 enrolled

Melanoma

NCT06080711 2023-10-12

AIDMel

30 enrolled

Melanoma, Skin Neoplasms

NCT04546074 2023-10-03

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Phase 1/2 Unknown

22 enrolled

Melanoma

NCT01586767 2023-09-21

Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

45 enrolled

CNSDermatologic

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Carcinoma, Adenoid Cystic, Fistula, Melanoma, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory

NCT04986696 2023-09-21

IMPulse

46 enrolled

Disease, Melanoma

NCT02858921 2023-08-30

Neo Trio

60 enrolled

Melanoma, Neoplasms

NCT04799106 2023-08-29

Community Based Strategies for Early Detection of Melanoma

Unknown

200 enrolled

Melanoma

NCT03808441 2023-08-25

CAcTUS

21 enrolled

Melanoma

NCT05798533 2023-07-10

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

Phase 1 Unknown

6 enrolled

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05827289 2023-07-06

CAPABLE

36 enrolled

Melanoma

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

43 enrolled

Melanoma

NCT05478473 2023-06-18

Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma

43 enrolled

Melanoma

NCT05906277 2023-06-15

Melamoma4p

300 enrolled

Melanoma

NCT05106023 2023-06-07

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

31 enrolled

DermatologicGenitourinaryHead & Neck

Melanoma

NCT04146064 2023-06-05

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Unknown

425 enrolled

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT04631731 2023-06-01

ICEMELT

Phase 1/2 Unknown

200 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT05854589 2023-05-11

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

20 enrolled

Melanoma

NCT03683550 2023-05-10

Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma

836 enrolled

Melanoma

NCT05827770 2023-04-25

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

20 enrolled

Melanoma

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

50 enrolled

Lung Neoplasms, Melanoma

NCT03528408 2023-04-11

Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma

52 enrolled

BreastDermatologicThoracic

Uveal Melanoma, Melanoma

NCT04821570 2023-04-04

CANINE

Unknown

500 enrolled

Breast Neoplasms, Lung Neoplasms, Melanoma

NCT05798546 2023-04-04

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

Phase 1 Unknown

21 enrolled

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05156515 2023-03-29

PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

20 enrolled

Lung Neoplasms, Melanoma

NCT05767879 2023-03-14

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

28 enrolled

Melanoma

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients